NicSnap1 inhibitors are a class of chemical compounds that interact with the NicSnap1 protein, a crucial component in cellular signaling pathways. These inhibitors are known for their ability to modulate specific biochemical interactions by selectively binding to the NicSnap1 protein, leading to a reduction in its activity. This modulation affects downstream pathways associated with various intracellular processes, including protein synthesis, cellular stress responses, and energy metabolism. The molecular structure of NicSnap1 inhibitors typically includes diverse chemical scaffolds that allow for a high degree of specificity in targeting NicSnap1. These compounds are designed to maintain strong binding affinity to the NicSnap1 active site, which is often facilitated by hydrophobic interactions, hydrogen bonding, and van der Waals forces, depending on the specific inhibitor's architecture.
NicSnap1 inhibitors can exhibit varied physicochemical properties, such as differing solubility, stability, and permeability, which can be fine-tuned during the development process. Researchers often investigate these properties to ensure the inhibitors perform well in controlled laboratory environments, particularly in experiments involving biochemical assays and protein interaction studies. The development of NicSnap1 inhibitors typically focuses on optimizing key parameters such as binding selectivity and minimization of off-target effects to better understand the mechanistic pathways of NicSnap1. Their distinct molecular makeup provides an important tool for studying the functional role of NicSnap1 in various biological processes, enabling detailed investigations into the protein's structural and functional dynamics in cellular systems.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Bafilomycin A1 | 88899-55-2 | sc-201550 sc-201550A sc-201550B sc-201550C | 100 µg 1 mg 5 mg 10 mg | $96.00 $250.00 $750.00 $1428.00 | 280 | |
Inhibits V-ATPase, potentially affecting vesicle trafficking and neurotransmitter release. | ||||||
Latrunculin A, Latrunculia magnifica | 76343-93-6 | sc-202691 sc-202691B | 100 µg 500 µg | $260.00 $799.00 | 36 | |
Disrupts actin polymerization, possibly influencing synaptic vesicle dynamics and neuron integrity. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
PI3K inhibitor, could impact signaling pathways involved in cell survival and synaptic function. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $97.00 $254.00 | 36 | |
Inhibits protein synthesis, potentially affecting neuron function and synaptic plasticity. | ||||||
KN-93 | 139298-40-1 | sc-202199 | 1 mg | $178.00 | 25 | |
Inhibits CaMKII, possibly influencing calcium signaling and synaptic strength. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
MEK inhibitor, could affect MAPK/ERK pathway involved in synaptic plasticity and memory formation. | ||||||
FK-506 | 104987-11-3 | sc-24649 sc-24649A | 5 mg 10 mg | $76.00 $148.00 | 9 | |
Inhibits calcineurin, potentially impacting T-cell activation and neuroinflammation. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
Inhibits PI3K, could impact various signaling pathways involved in cell growth and survival. | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $62.00 $90.00 $299.00 $475.00 $1015.00 $2099.00 | 69 | |
Calcineurin inhibitor, might modulate immune response and neuroprotection. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
p38 MAPK inhibitor, could influence inflammatory responses and cellular stress pathways. | ||||||